Trial intelligence / Profile preview

Preoperative CR Oxycodone vs Intraoperative Morphine for VATS

NCT00681174Phase 4Terminated

Sponsor
University of Parma
Start
Jul 2008
Primary completion
Nov 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of oxycodone in postoperative pain (2 arms), sponsored by University of Parma. Primary endpoint: Morphine consumption (intravenous titration in PACU + i.v. patient-controlled pump usage) at 48 hours. Started Jul 2008; status: terminated.

02

Drugs

oxycodone
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT00681174.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00681174.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call